Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,381.10
+8.40 (0.35%)
Jun 12, 2026, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 982.99 billion as of June 12, 2026. Its market cap has decreased by -2.07% in one year.
Market Cap
982.99B
Enterprise Value
1.03T
Revenue
142.78B
Ranking
n/a
PE Ratio
51.45
Stock Price
2,381.10
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 982.99B, an increase of 72.53%. That is a compound annual growth rate of 19.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 982.99B | 8.41% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.76T |
| Cipla | 1.12T |
| Zydus Lifesciences | 1.11T |
| Aurobindo Pharma | 847.42B |
| Laurus Labs | 752.72B |
| Alkem Laboratories | 633.46B |
| Glenmark Pharmaceuticals | 613.45B |
| Ipca Laboratories | 401.61B |